Marcela Segatto

Dr. Marcela Segatto

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2011 in Microbes and Infection
Verified
Journal Article
Closed access
AFAdaliene Ferreira
Adaliene Ferreira
MSMarcela Segatto
Marcela Segatto
ZMZélia Menezes
Zélia Menezes
AMAndréa Mara Macedo
Andréa Mara Macedo
CGCláudio Gelape
Cláudio Gelape
HTHerbert B. Tanowitz
Herbert B. Tanowitz

2 October 2019 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
Juliana Brambilla Carnielli TrindadeJuliana Brambilla Carnielli Trindade
Juliana Brambilla Carnielli Trindade
RMRenata Monti-Rocha
Renata Monti-Rocha
DCDorcas Lamounier Costa
Dorcas Lamounier Costa
ASAretha Molina Sesana
Aretha Molina Sesana
LPLaura N. N. Pansini
Laura N. N. Pansini
RDReynaldo Dietze
Reynaldo Dietze
In India, visceral leishmaniasis (VL) caused by Leishmania donovani has been successfully treated with miltefosine with a cure rate of > 90%. To assess the efficacy and safety of oral miltefosine against Brazilian VL, which is caused by Leishmania infantum, a phase II, open-label, dose-escalation study of oral miltefosine was conducted in children (aged 2–12 years) and adolescent-adults (aged 13–60 years). Definitive cure was assessed at a 6-month follow-up visit. The cure rate was only 42% (6 of 14 patients) with a recommended treatment of 28 days and 68% (19 of 28 patients) with an extended treatment of 42 days. The in vitro miltefosine susceptibility profile of intracellular amastigote stages of the pretreatment isolates, from cured and relapsed patients, showed a positive correlation with the clinical outcome. The IC50 mean (SEM) of eventual cures was 5.1 (0.4) µM, whereas that of eventual failures was 12.8 (1.9) µM (P = 0.0002). An IC50 above 8.0 µM predicts failure with 82% sensitivity and 100% specificity. The finding of L. infantum amastigotes resistant to miltefosine in isolates from patients who eventually failed treatment strongly suggests natural resistance to this drug, as miltefosine had never been used in Brazil before this trial was carried out.

1 March 2014 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
RBRodrigo de Paula Baptista
Rodrigo de Paula Baptista
DDDaniella Alchaar D’áVila
Daniella Alchaar D’áVila
MSMarcela Segatto
Marcela Segatto
ÍVÍtalo Faria Do Valle
Ítalo Faria Do Valle
GFGlória Regina Franco
Glória Regina Franco
AMAndréa Mara Macedo
Andréa Mara Macedo

10 July 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
HVHelder Magno Silva Valadares
Helder Magno Silva Valadares
JPJuliana Ramos Pimenta
Juliana Ramos Pimenta
MSMarcela Segatto
Marcela Segatto
VVVanja Maria Veloso
Vanja Maria Veloso
MGMônica Lúcia Gomes
Mônica Lúcia Gomes
AMAndréa Mara Macedo
Andréa Mara Macedo
Trypanosoma cruzi, the etiological agent of Chagas disease, is a polymorphic species. Evidence suggests that the majority of the T. cruzi populations isolated from afflicted humans, reservoir animals, or vectors are multiclonal. However, the extent and the complexity of multiclonality remain to be established, since aneuploidy cannot be excluded and current conventional cloning methods cannot identify all the representative clones in an infection. To answer this question, we adapted a methodology originally described for analyzing single spermatozoids, to isolate and study single T. cruzi parasites. Accordingly, the cloning apparatus of a Fluorescence-Activated Cell Sorter (FACS) was used to sort single T. cruzi cells directly into 96-wells microplates. Cells were then genotyped using two polymorphic genomic markers and four microsatellite loci. We validated this methodology by testing four T. cruzi populations: one control artificial mixture composed of two monoclonal populations – Silvio X10 cl1 (TcI) and Esmeraldo cl3 (TcII) – and three naturally occurring strains, one isolated from a vector (A316A R7) and two others derived from the first reported human case of Chagas disease. Using this innovative approach, we were able to successfully describe the whole complexity of these natural strains, revealing their multiclonal status. In addition, our results demonstrate that these T. cruzi populations are formed of more clones than originally expected. The method also permitted estimating of the proportion of each subpopulation of the tested strains. The single-cell genotyping approach allowed analysis of intrapopulation diversity at a level of detail not achieved previously, and may thus improve our comprehension of population structure and dynamics of T. cruzi. Finally, this methodology is capable to settle once and for all controversies on the issue of multiclonality. Trypanosoma cruzi, the cause of Chagas disease, is responsible for high levels of mortality and morbidity in many countries of Latin America. This species is very polymorphic and was recently classified into six discrete typing units (TcI-VI) that are associated with different geographical distribution, transmission cycles, and varying disease symptoms. Natural parasite populations are thought to have a complex structure since in endemic areas the same hosts may be simultaneously infected by different T. cruzi strains due to frequent exposure to insects as well as the variety of reservoirs and vectors in the sylvatic environment and the heterogeneous composition of the parasite populations. Most of the putative multiclonal populations have been suggested based on indirect evidence, or current conventional cloning methods that may favor some individuals' growth. In an effort to elucidate the complexity of T. cruzi isolates we adapted a methodology originally described for analyzing single spermatozoids, to sort single parasites. This approach allowed us to completely dissect the complexity of four strains and estimate the relative contribution of each subpopulation. Knowledge about complexity of T. cruzi strains is essential for determining the aspects involved in differential parasite tissue tropism, clinical manifestations of the disease, and drug resistance.

1 May 2012 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
LBLuís Fábio da S. Batista
Luís Fábio da S. Batista
MSMarcela Segatto
Marcela Segatto
CGCarlos Eduardo S. Guedes
Carlos Eduardo S. Guedes
RSRosana S. Sousa
Rosana S. Sousa
CRCleusa A. T. Rodrigues
Cleusa A. T. Rodrigues
PVPatrícia Veras
Patrícia Veras
Correlations between the genetic diversity of Leishmania infantum (syn. L. chagasi) isolates and their respective geographic origins support the theoretic assumption that visceral leishmaniasis probably originated in the Old World. Because dogs are widely considered to be the main reservoir of this disease, the present study aimed to investigate the degree of genetic divergence among 44 leishmanial canine isolates from two Brazilian cities, Jequié and Campo Grande, located approximately 2,028 km from each other. We hypothesized that a low degree of genetic divergence would be observed among these isolates. In fact, statistical analyses found no significant differences between the isolates using both random amplified polymorphic DNA and multilocus microsatellite typing genotyping techniques with three and seven markers, respectively. These findings provide support for the recent introduction of L. infantum into the New World.

21 February 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
CRCamila Favoreto Do Rosário
Camila Favoreto Do Rosário
WNWalker Garcia Fernandes Neto
Walker Garcia Fernandes Neto
APAndré Luiz Pessotti
André Luiz Pessotti
BRBeatriz Cardoso Rodrigues
Beatriz Cardoso Rodrigues
JBJuliana Diniz Baptista
Juliana Diniz Baptista
JJJosé Antônio Fiorot Júnior
José Antônio Fiorot Júnior
Background: Stroke is a public health problem. For patients with ischemic stroke, venous thrombolysis and mechanical thrombectomy are effective therapeutic options. However, even after the National Stroke Treatment Guidelines were published in 2012, the number of cases treated is still lower than expected. Objective: To identify the determining factors for obtaining access to acute-phase therapies in the state of Espírito Santo (ES) and investigate the profile of stroke patients treated at the Central State Hospital (HEC). Methods: Retrospective data from the medical records of 1078 patients from May 2018 to December 2019 were analyzed. Results: Among the 1,078 patients, 54.9% were men and the most prevalent age group was 60 to 79 years. Systemic arterial hypertension was the main single risk factor. Regarding treatment modality among the patients who arrived at the HEC within the therapeutic window, 47% received some type of acute-phase therapy. Waking up with the deficit was the main contraindication for venous thrombolysis in these cases. Conclusions: Application of the flowchart established by SESA-ES seemed to be effective for enabling responsiveness of care for stroke victims. Public emergency transport services had a fundamental role in this process. In addition, the care provided by the tertiary stroke center provided excellent access to acute-phase therapies. However, despite the efficiency of the service provided at the HEC, it only reached a maximum of 50% of the ES population. This service model therefore needs to be expanded throughout the state.